A summary of the pharmacologic management of acute bleeding and secondary prevention of bleeds in LVAD patients.

Supportive Measures 
Device Factors 
Octreotide
Desmopressin 
Anti-secretory Agents (H2RA, PPI)

Secondary Prevention:
RAAS blockade
Thalidomide
Danazol
Anticoagulation

#LVAD #Bleeding #Pharmacology #Management #Treatment #Medications #Secondary #Prevention
Dr. Gerald Diaz @GeraldMD · 5 years ago
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief πŸ‡΅πŸ‡­ πŸ‡ΊπŸ‡Έ - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Related images